Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-021378 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 24, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
36,000
Total Value
$2,297,040.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 22, 2026 | Exercise/Conversion | 12,000 | $3.50 | $42,000.00 | 54,588 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 22, 2026 | Sale | 12,000 | $187.92 | $2,255,040.00 | 42,588 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 22, 2026 | Exercise/Conversion | 12,000 | $0.00 | $0.00 | 105,000 | Direct | โ | View Details |